Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002

Leukemia volume 17, pages 798–803 (2003)Cite this article

Participating Groups/Institutions (participants): Associazione Italiana Ematologia ed Oncologia Pediatrica (M Arico, G Basso, A Biondi, G Masera, MG Valsecchi), Berlin-Frankfurt-Münster (H Gadner, O Hass, J Harbott, R Panzer, H Riehm, M Schrappe, A Stackelberg, M Stanulla, M Zimmermann), Children's Oncology Group (B Camitta, B Carroll, M Devidas, P Gaynon, N Heerema, J Nachman), Cooperative Acute Lymphoblastic Leukemia (G Janka-Schaub), Czech Republic ALL Study Group (J Trka), Dana-Farber Cancer Institute (L Silverman), Dutch Childhood Leukemia Study Group (R Pieters, E van den Berg-de Ruiter, A van der Does, A Veerman), European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group (H Cave, S Suciu, E Vilmer), French Acute Lymphoblastic Leukemia Study Group (A Baruchel), Japan Association of Childhood Leukemia Study (K Horibe), Medical Research Council, United Kingdom Acute Lymphoblastic Leukemia (OB Eden, C Harrison), Nordic Society of Paediatric Haemotology and Oncology (E Forestier, G Gustafsson, K Schmiegelow), St Jude Children's Research Hospital (C-H Pui, MV Relling), Tokyo Children's Cancer Study Group (A Manabe, M Tsuchida), Guests: S Corbacioglu, Switzerland, S Izraeli, Israel

Supported in part by the Österreichische Kinderkrebshilfe and by private donations to the Children's Cancer Research Institute; by the Associazione Italiana Ricerca sul Cancro, Fondazione Tettamanti, and Consiglio Nazionale Ricerche-Ministero Istruzione Universitá Ricerca; grants from the US National Institute of Health (CA-21765, CA-51001, CA-31566, CA-78824, CA-29139, and CA-37379), a Center of Excellence grant from the State of Tennessee, and the American Lebanese Syrian Associated Charities (ALSAC); the Deutsche Krebshilfe, Bonn, and Madeleine Schickedanz Foundation, Fürth, Germany. C-H Pui is the American Cancer Society – FM Kirby Clinical Research Professor

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Schrappe M, Camitta B, Pui CH . Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 2193–2194.

    Article  CAS  PubMed  Google Scholar 

  2. Pui CH, Evans WE, Gilbert JR . Meeting report: International childhood ALL workshop. Memphis, TN, 3–4 December 1997. Leukemia 1998; 8: 1313–1318.

    Article  Google Scholar 

  3. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 1: 18–24.

    Article  Google Scholar 

  4. Pui CH, Schrappe M, Camitta B . Normal and malignant hemopoiesis: spotlight on long-term results of pediatric ALL clinical trials from study 12 groups world wide. Leukemia 2000; 14: 2193–2320.

    Article  PubMed  Google Scholar 

  5. Pui CH, Sallan S, Relling MV, Masera G, Evans WE . Inter-national Childhood Acute Lymphoblastic Leukemia Workshop. Sausalito, CA, 30 November–1 December 2000. Leukemia 2001; 15: 707–715.

    Article  CAS  PubMed  Google Scholar 

  6. Aricò M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998–1006.

    Article  PubMed  Google Scholar 

  7. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909–1915.

    Article  PubMed  Google Scholar 

  8. Chessells JM, Harrision CJ, Watson SL, Vora AJ, Richards SM . Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999. Br J Haematol 2002; 117: 306–314.

    Article  CAS  PubMed  Google Scholar 

  9. Forestier E, Johansson B, Gustafsson G, Borgstrom G, Kerndrup G, Johannsson J et al. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. Br J Haematol 2000; 110: 147–153.

    Article  CAS  PubMed  Google Scholar 

  10. Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG et al. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 1998; 12: 346–352.

    Article  CAS  PubMed  Google Scholar 

  11. Bo J, Schroder H, Kristinsson J, Madsen B, Szumlanski C, Weinshilboum R et al. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer 1999; 86: 1080–1086.

    Article  CAS  PubMed  Google Scholar 

  12. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 1998; 95: 13176–13181.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM et al. Prevalence of the inactivating 609C–>T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999; 94: 803–807.

    CAS  PubMed  Google Scholar 

  14. Blanco JG, Edick MJ, Schuster JJ, Dervieux T, Amylon MD, Bash RO et al. Genetic polymorphisms in NQO1 and CYP3A4 in children with treatment-related acute myeloid malignancies. Blood 2001; 98: 323a (abstract 1365).

  15. Blanco JG, Dervieux T, Edick MJ, Mehta PK, Rubnitz JE, Shurtleff S et al. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2001; 98: 10338–10343.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood. Lancet 1998; 352: 1731–1738.

    Article  CAS  PubMed  Google Scholar 

  17. Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S . AML1 gene amplification a novel finding in childhood acute lymphoblastic leukemia. Haematologica 2000; 85: 362–366.

    CAS  PubMed  Google Scholar 

  18. Busson-Le Coniat M, Nguyen Khac F, Daniel MT, Bernard OA, Berger R . Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001; 32: 244–249.

    Article  CAS  PubMed  Google Scholar 

  19. Dal Cin P, Atkins L, Ford C, Ariyanayagam S, Armstrong SA, George R et al. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer 2001; 30: 407–409.

    Article  CAS  PubMed  Google Scholar 

  20. Penther D, Preudhomme C, Talmant P, Roumier C, Godon A, Mechinaud F et al. Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 2002; 16: 1131–1134.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children's Cancer Research Institute and St. Anna Kinderspital, Vienna, Austria

    H Gadner & O A Haas

  2. Associazione Italiana di Ematologia ed Oncologia Pediatrica and Centro Ricerca M. Tettamanti, Clinica Pediatrica, Università Milano-Bicocca, Monza, Italy

    G Masera

  3. St. Jude Children's Research Hospital and the University of Tennessee, Memphis, TN, USA

    C-H Pui

  4. Berlin-Frankfurt Münster Study Group, and Department of Pediatric Hematology and Oncology, Children's Hospital, Hannover Medical School, Hannover, Germany

    M Schrappe

Authors
  1. H Gadner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O A Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Masera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C-H Pui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Schrappe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H Gadner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gadner, H., Haas, O., Masera, G. et al. ‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002. Leukemia 17, 798–803 (2003). https://doi.org/10.1038/sj.leu.2402872

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402872

This article is cited by

Search

Advanced search

Quick links